• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Development of a 6-endo-selective bromoetherification

Development of a 6-endo-selective bromoetherification

Christoph Lentsch (ORCID: )
  • Grant DOI 10.55776/J3599
  • Funding program Erwin Schrödinger
  • Status ended
  • Start August 6, 2014
  • End August 5, 2016
  • Funding amount € 70,900

Disciplines

Chemistry (90%); Physics, Astronomy (10%)

Keywords

    6-endo-selective bromoetherification, Microcladallene, Natural Product, BDSB, Total Synthesis

Abstract Final report

The steadily increasing demand for new drugs for the treatment of various diseases and the urgent need for new antibiotic scaffolds, result in an unbroken interest in the isolation of natural products. Over decades natural products inspired synthetic chemists efforts and constituted the basis for the identification of different drugs available today. In recent years, especially marine natural products have attained growing attention, because of the frequent occurrence of uncommon structural motifs leading to novel biological mechanisms of action. As the marine environment is very hostile, these metabolites are often stable to harsh salty conditions, and exhibit extraordinary potency to circumvent the activity-diminishing diluting effect. Among the isolated maritime natural products numerous halide-containing structures can be found. Unfortunately, by now there are only very few synthetic methods available dealing with the accessibility of sp3 C-X bonds. The formation of 6-membered haloethers, in particular, represents a striking challenge in natural product synthesis. To face this challenge and be able to design short and efficient syntheses toward various halogenated natural haloethers the proposal describes the elaboration of a general protocol for a 6-endo selective bromoetherification reaction. The ambitious task to overcome the kinetically favored 5-exo bromoetherification reaction is the most exciting endeavor presented. Furthermore, the combination with a selective epoxide opening reaction will extend the scope of the bromoetherification reaction tremendously and open access to different classes of halogenated natural products. Additionally, making these natural products easier accessible will help to provide necessary quantities for comprehensive biological studies. In order to demonstrate the general applicability of the newly developed concept we will also accomplish the synthesis of microcladallene, a C15 acetogenin, isolated from red algae Laurencia microcladia. A fast and effective access to microcladallene would be additionally desirable, because due to the highly interesting structural features this bromoether will be extensively analyzed concerning its biological effectiveness within pharmacological studies at Scripps Florida. Critically, the newly developed bromoetherification reaction should be successfully applied in the total synthesis of a marine natural product, and show the general application in presence of diverse functionalities.

Biology, chemistry and medicine have always been closely linked, not only, but especially when it comes to finding new drugs. Many natural substances were isolated from herbs or medicinal plants, their structure elucidated and their biological activity tested. Some of these natural products served as the basis for the development of new drugs. Due to a steadily growing demand for new drugs for the treatment of various diseases and the urgent need for new antibiotics, there is an unbroken interest in the isolation of new natural products. In recent years, especially marine natural products have attained growing attention, because of the frequent occurrence of uncommon structural motifs leading to novel biological mechanisms of action. As the marine environment is very hostile, these metabolites are often stable to harsh salty conditions, and exhibit extraordinary potency to circumvent the activity-diminishing diluting effect. Due to the very small amount of isolated natural products, it is often necessary to create these molecules on a larger scale in the laboratory. Herein, especially the incorporation of halides represents a striking challenge to the natural product chemist. Particularly the access to 6-membered haloethers, which are a very frequent component of maritime natural products, has so far only been possible on a very cumbersome path. Over the last two years, a new method to provide faster access to this complex structural element has been successfully developed in the course of this project. In principle, the development of a new method in chemistry can be compared with the addition of a new tool to a toolbox. Not every tool is equally suitable for every task, but if you have the right tool for a given job, you can do it very efficiently. The newly developed protocol is very robust and tolerates a variety of different functional groups to allow for a broad synthetic application. In this case, the newly developed method facilitates access to the aforementioned 6-membered haloethers. This method makes it easier to provide the required amounts of different natural substances for comprehensive biological investigations, in order to identify possible active ingredients or lead structures.

Research institution(s)
  • Universität Wien - 100%

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF